Palmitoylated prolactin-releasing peptide reduced A β plaques and microgliosis in the cerebellum: APP/PS1 mice study
CONCLUSION: These results suggest palm11-PrRP31 is a promising agent for the treatment of neurodegenerative disorders.PMID:34551697 | DOI:10.2174/1567205018666210922110652
Source: Current Alzheimer Research - Category: Neurology Authors: Anna Mengr Lucie Hrub á Aneta Exnerov á Martina Holubov á Andrea Popelov á Blanka Železná Jaroslav Kune š Lenka Malet ínská Source Type: research
More News: Alzheimer's | Brain | Calcium | Cerebellum | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Men | Neurology | Obesity | Pathology | Study